Geron Corporation

Contributing Author

Recent Articles by Geron Corporation

Jun-01	Geron to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference GERN GlobeNewswire
May-18	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
May-12	First Real-World Evidence Study of RYTELO (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026 GERN GlobeNewswire
May-06	Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights GERN GlobeNewswire
May-05	Geron Plans to Present at Upcoming Investor Conferences GERN +5.10% GlobeNewswire
Apr-22	Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 GERN GlobeNewswire
Apr-20	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN -7.14% GlobeNewswire
Apr-14	Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Apr-13	Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary GERN GlobeNewswire
Apr-06	Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference GERN +5.42% GlobeNewswire
Mar-26	Geron Announces Appointment of New Members to its Board of Directors GERN GlobeNewswire
Mar-18	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Feb-25	Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights GERN -11.79% GlobeNewswire
Feb-23	Geron Plans to Present at Upcoming Investor Conferences GERN -5.85% GlobeNewswire
Feb-18	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN +7.78% GlobeNewswire
Feb-11	Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 GERN GlobeNewswire
Jan-12	Geron Corporation Provides 2026 Financial Guidance GERN +6.72% GlobeNewswire
Dec-18	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire
Dec-11	Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation GERN +8.59% GlobeNewswire
Dec-08	Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO (Imetelstat) in Lower-Risk MDS GERN GlobeNewswire
Oct-13	Geron Corporation Announces Executive Leadership Transitions and Appointments GERN GlobeNewswire
Sep-18	Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GERN GlobeNewswire

Geron Corporation

Recent Articles by Geron Corporation

Upgrade your Finviz experience